Find clinical trials for Diabetes in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Foot Ulcer

Obesity

Ulcer

Diabetes trials near Phoenix, AZ, USA:

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting

Recent Onset type1 Diabetes

Drug: Placebo

Drug: Ladarixin

Phase 2

Dompé

Phoenix, Arizona, United States and 56 other locations

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling

Type 2 Diabetes

Obesity

Drug: Tirzepatide

Drug: Placebo

Phase 2

Lilly

Tempe, Arizona, United States and 42 other locations

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (CENTRICITY)

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting

Type 2 Diabetes

Nonalcoholic Steatohepatitis (NASH)

Drug: Placebo

Drug: HTD1801

Phase 2

HighTide Therapeutics

Peoria, Arizona, United States and 47 other locations

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling

Type 2 Diabetes

Drug: Retatrutide

Drug: Placebo

Phase 3

Lilly

Sun City West, Arizona, United States and 81 other locations

Status recently updated

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Not yet enrolling

Enrolling

Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Drug: Maridebart cafraglutide

Drug: Placebo

Phase 3

Amgen

Gilbert, Arizona, United States and 28 other locations

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects with Moderately Severe to Severe Non-proliferative Diabetic Retinopat...

Active, not recruiting

Non-proliferative Diabetic Retinopathy

Drug: OTX-TKI

Drug: Sham

Phase 1

Ocular Therapeutix

Phoenix, Arizona, United States and 9 other locations

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers (Mavericks)

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling

Diabetic Foot Ulcer

Device: COMS One device

Device: Sham device

Piomic Medical

Mesa, Arizona, United States and 23 other locations

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...

Enrolling

Type 2 Diabetes Mellitus

Drug: LY3209590

Phase 1

Lilly

Scottsdale, Arizona, United States and 10 other locations

Locations recently updated

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Phoenix, Arizona, United States and 119 other locations

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting

Diabetic Retinopathy

Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab

Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche

Phoenix, Arizona, United States and 75 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Phoenix, AZ

Related conditions:

Diabetes trials near Phoenix, AZ, USA:

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (CENTRICITY)

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers (Mavericks)

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Find clinical trials for Diabetes in Phoenix, AZ